PMID- 34278242 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220813 IS - 2577-3240 (Electronic) IS - 2577-3240 (Linking) VI - 3 IP - 1 DP - 2020 Feb TI - Molecular Mechanisms of Intermittent Fasting-induced Ischemic Tolerance. PG - 9-17 AB - Diet is a significant factor in determining human well-being. Excessive eating and/or diets with higher than needed amounts of carbohydrates, salt, and fat are known to cause metabolic disorders and functional changes in the body. To compensate the ill effects, many designer diets including the Mediterranean diet, the Okinawa diet, vegetarian/vegan diets, keto diet, anti-inflammatory diet, and the anti-oxidant diet have been introduced in the past 2 decades. While these diets are either enriched or devoid of one or more specific components, a better way to control diet is to limit the amount of food consumed. Caloric restriction (CR), which involves limiting the amount of food consumed rather than eliminating any specific type of food, as well as intermittent fasting (IF), which entails limiting the time during which food can be consumed on a given day, have gained popularity because of their positive effects on human health. While the molecular mechanisms of these 2 dietary regimens have not been fully deciphered, they are known to prolong the life span, control blood pressure, and blood glucose levels. Furthermore, CR and IF were both shown to decrease the incidence of heart attack and stroke, as well as their ill effects. In particular, IF is thought to promote metabolic switching by altering gene expression profiles leading to reduced inflammation and oxidative stress, while increasing plasticity and regeneration. FAU - Vemuganti, Raghu AU - Vemuganti R AD - Department of Neurological Surgery, University of Wisconsin, Madison, WI, USA. AD - William S. Middleton VA Hospital, Madison, WI, USA. FAU - Arumugam, Thiruma V AU - Arumugam TV AD - Department of Physiology, National University of Singapore, Singapore. LA - eng GR - R01 NS109459/NS/NINDS NIH HHS/United States PT - Journal Article PL - United States TA - Cond Med JT - Conditioning medicine JID - 101718750 PMC - PMC8281895 MID - NIHMS1594284 OTO - NOTNLM OT - Brain OT - Dietary restriction OT - Inflammation OT - Neuroprotection OT - Oxidative stress OT - Stroke EDAT- 2020/02/01 00:00 MHDA- 2020/02/01 00:01 PMCR- 2021/07/15 CRDT- 2021/07/19 06:05 PHST- 2021/07/19 06:05 [entrez] PHST- 2020/02/01 00:00 [pubmed] PHST- 2020/02/01 00:01 [medline] PHST- 2021/07/15 00:00 [pmc-release] PST - ppublish SO - Cond Med. 2020 Feb;3(1):9-17.